| |
| |
|
| Insider
Information: |
Worboys Philip D |
| Relationship: |
SVP, Research & Transl... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
335,062 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,055,765 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
335,062 |
|
|
| Total
Value |
$3,055,765 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -102.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Theravance Biopharma, Inc. |
TBPH |
SVP, Research & Transl... |
2021-08-20 |
335,062 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2021-08-20 |
4 |
D |
$14.05 |
$60,513 |
D/D |
(4,307) |
335,062 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2021-05-20 |
4 |
D |
$17.80 |
$76,718 |
D/D |
(4,310) |
339,369 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2021-03-09 |
4 |
S |
$20.00 |
$176,580 |
D/D |
(8,829) |
343,679 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2021-02-20 |
4 |
D |
$18.79 |
$599,157 |
D/D |
(31,887) |
352,508 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2021-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
384,395 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2020-12-03 |
4 |
S |
$18.00 |
$76,428 |
D/D |
(4,246) |
319,395 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2020-11-20 |
4 |
D |
$17.21 |
$82,728 |
D/D |
(4,807) |
323,641 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2020-08-20 |
4 |
S |
$18.00 |
$307,854 |
D/D |
(17,103) |
333,252 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2020-08-20 |
4 |
D |
$18.22 |
$87,529 |
D/D |
(4,804) |
328,448 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2020-05-20 |
4 |
D |
$26.67 |
$128,203 |
D/D |
(4,807) |
350,355 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2020-02-20 |
4 |
D |
$25.90 |
$753,820 |
D/D |
(29,105) |
354,750 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2020-02-03 |
4 |
A |
$0.00 |
$0 |
D/D |
119,000 |
383,855 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Research & Transl Science |
• – – |
2019-11-20 |
4 |
D |
$17.60 |
$39,987 |
D/D |
(2,272) |
264,855 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2019-08-20 |
4 |
D |
$21.51 |
$48,871 |
D/D |
(2,272) |
267,127 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2019-05-20 |
4 |
D |
$19.84 |
$45,076 |
D/D |
(2,272) |
269,399 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2019-02-20 |
4 |
D |
$27.00 |
$107,622 |
D/D |
(3,986) |
270,644 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2019-02-05 |
4 |
A |
$0.00 |
$0 |
D/D |
112,250 |
274,630 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2018-11-20 |
4 |
D |
$24.79 |
$108,407 |
D/D |
(4,373) |
162,380 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2018-09-12 |
4 |
S |
$28.50 |
$182,201 |
D/D |
(6,393) |
166,753 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2018-08-20 |
4 |
D |
$26.95 |
$148,441 |
D/D |
(5,508) |
173,146 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2018-05-20 |
4 |
D |
$24.31 |
$474,628 |
D/D |
(19,524) |
178,654 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2018-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
33,750 |
198,178 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2018-02-20 |
4 |
D |
$29.09 |
$132,825 |
D/D |
(4,566) |
163,563 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2018-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
168,129 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, Translational Science |
• – – |
2017-11-20 |
4 |
D |
$28.58 |
$157,276 |
D/D |
(5,503) |
159,129 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
